LIGAND PHARMACEUTICALS INCORPORATED Finance Lease, Liability, Undiscounted Excess Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Finance Lease, Liability, Undiscounted Excess Amount of $6.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-27
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.00K.
- 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $11.00K.
- 2023-12-31: Finance Lease, Liability, Undiscounted Excess Amount $5.00K.
- 2022-12-31: Finance Lease, Liability, Undiscounted Excess Amount $1.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $6.00K 10-K · filed 2026-02-27 |
| 2024-12-31 | $11.00K 10-K · filed 2025-02-28 |
| 2023-12-31 | $5.00K 10-K · filed 2024-02-29 |
| 2022-12-31 | $1.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $5.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $53.00K 10-K · filed 2021-02-24 |